-
HPA042449-100
Anti-SYMPK symplekin, 100ul UN 1687 6.1 PG2 (C003B-082489)
Price: $1,108.10List Price: $1,231.23Anti-SYMPK symplekin, 100ul UN 1687 6.1 PG2 -
D408566-1ml
Dinaciclib (SCH727965) (C007B-136808)
Price: $488.45List Price: $542.72InformationDinaciclib (SCH727965, PS-095760) is a novel and potent CDK inhibitor forCDK2,CDK5,CDK1andCDK9withIC50of 1 nM, 1 nM, 3 nM and 4 nM in cell-free assays, respectively. It also blocks thymidine (dThd) DNA incorporation. Dinaciclib induces -
Lib412084-100μl-well
FDA-approved Anticancer Drug Library
Price: $35,587.29List Price: $39,541.43InformationA unique collection of 1677 approved drugs with anticancer activity used for high throughput screening(HTS) and high content screening(HCS).Description & Advantages•A unique collection of 1721 approved drugs with anticancer activity -
L58230REVF
Label,Pall,3 Color 3.74 Inch x 2.756 Inch, 1000/RL Cost at 5 Rolls
Price: $898.33List Price: $998.15The CLEANMARK® pall caution label is used in cleanroom environments. It is used in semiconductor, data storage, biotechnology and pharmaceutical industries. It is easy to use and convenient to handle. -
GBM-4760-25MG
Palbociclib (PD0332991) (C009B-006182)
Price: $451.84List Price: $502.04Palbociclib (PD0332991) -
GBM-4760-5MG
Palbociclib (PD0332991) (C009B-006183)
Price: $175.71List Price: $195.24Palbociclib (PD0332991) -
P651564-1mg
Palbociclib-d8
Price: $414.77List Price: $460.86Palbociclib-d 8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has the potential for ER-positive and HER2-negative breast cancer